Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...

UnitedHealth Group reported mixed financial results for Q4, with a rise in medical care ratio and CEO's tribute to the late ...

A bill before the Arkansas legislature would prevent pharmacy benefit managers (PBMs) or insurance companies from obtaining ...

Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...

A recent Federal Trade Commission report highlights a concerning trend in the pharmaceutical industry, where pharmacy benefit ...

The Federal Trade Commission accused UnitedHealth's OptumRx, CVS Caremark, and Cigna's Express Scripts of pocketing over $7 ...

UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...

Says that while the company offers customers 100% pass-through options, “a small number have historically elected other models.” Witty says “We ...

The CEO of UnitedHealth Group said Thursday that shortcomings of America’s health care system must be addressed.

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

UnitedHealth Group (UNH) stock ends a turbulent year with a quarterly revenue miss amid regulatory challenges and public ...